Global Market News
NCATS inks drug-screening partnership with Lilly
The drug company Eli Lilly will screen more than 3,800 approved and investigational medicines to find potential new uses for the drugs in a partnership with the US National Center for Advancing Translational Sciences (NCATS).
For more information, click here.
Return to Previous Page